Piperidinylamino-thieno[2,3-D] pyrimidine compounds
US7612078B2 · kind B2 · utility
0Cited by
31References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2005 |
| Grant date | Nov 3, 2009 |
| Priority date | — |
| Expiry date | Dec 22, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to 5-HT receptor modulators, particularly 5-HT2B antagonists. Novel piperidinylamino-thieno[2,3-d]pyrimidine compounds represented by Formula I, II and III, and uses thereof for treating conditions including pulmonary arterial hypertension, congestive heart failure, and hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.